Chronic persistent Norovirus in the immune-compromised host

Chronic norovirus infection in immunocompromised individuals remains an under-recognized and difficult-to-treat condition. Future progress requires development of evidence-based antiviral therapies, and effective vaccines to mitigate long-term morbidity.